Fetal TEI Index in Pregnancies with Intrahepatic Cholestasis of Pregnancy: A Case-Control Study

Abstract

Objectives

First, to explore differences in fetal cardiac function in patients with and without intrahepatic cholestasis of pregnancy (ICP) based on the TEI index. Second, to explore a potential correlation between TEI index and bile acid levels in pregnant women with ICP. Third, to study changes in the TEI index of fetuses from pregnant women with ICP after administration of ursodeoxycholic acid (UDCA).

Study Design

This is a prospective observational case-control study conducted at Hospital Clínico San José and Clínica RedSalud Vitacura, both in Santiago, Chile, between April 2018 and October 2020. ICP was defined as palmar-plantar pruritus of nocturnal predominance for more than 1 week associated with a total bile acid level above 10 μmol/L. Control cases were women with pregnancies scheduled for induction or elective cesarean section between 37 and 40 weeks of gestation according to current protocols. Differences in the TEI index between cases and controls were assessed by the Wilcoxon test. The correlation between the TEI index and bile acid levels was assessed by the Spearman correlation test. Changes in TEI index before and after administration of UDCA were analyzed by the paired samples Wilcoxon test.

Results

A total of 181 pregnant women were included in the study, 109 women with ICP and 72 controls. The median gestational age at inclusion was 35.9 weeks (interquartile range [IQR], 33.0–38.9). The median TEI index was 0.31 (IQR, 0.29–0.36); this was significantly longer in fetuses of women with ICP ([0.34, IQR, 0.30–0.38] vs. [0.30, IQR, 0.28–0.31], p < 0.001). There was a significant correlation between bile acid levels and TEI index (0.584, p < 0.001). In 21 fetuses, the TEI index was measured a second time, 2 weeks later, following UDCA administration. The median TEI index decreased significantly following UDCA administration (0.40 ms before treatment [IQR, 0.36–0.42] vs. 0.33 after treatment [IQR, 0.32–0.38], p = 0.001), p = 0.001).

Conclusion

The TEI index is increased in fetuses of women with ICP. TEI index was significantly correlated with bile acid levels, and administration of UDCA significantly reduced the TEI index.

Key Points

• Significant correlation between TEI index and bile acid levels.

• Effect of UDCA treatment.

• clinical implications for monitoring and treatment.

Keywords

TEI Index - intrahepatic cholestasis of pregnancy - bile acids - ursodeoxycholic acid - transaminitis

Publikationsverlauf

Eingereicht: 12. August 2024

Angenommen: 16. August 2024

Accepted Manuscript online:
20. März 2025

Artikel online veröffentlicht:
16. April 2025

• References

• 1 Binah O, Rubinstein I, Bomzon A, Better OS. Effects of bile acids on ventricular muscle contraction and electrophysiological properties: studies in rat papillary muscle and isolated ventricular myocytes. Naunyn Schmiedebergs Arch Pharmacol 1987; 335 (02) 160-165
• 2 Gorelik J, Harding SE, Shevchuk AI. et al. Taurocholate induces changes in rat cardiomyocyte contraction and calcium dynamics. Clin Sci (Lond) 2002; 103 (02) 191-200
• 3 Zhang LJ, Xiang H, Ding YL. [Influence of total bile acid in maternal serum and cord blood on neonatal cardiac function from intrahepatic cholestasis of pregnancy]. Zhonghua Fu Chan Ke Za Zhi 2009; 44 (03) 188-190
• 4 Germain A, Gonzalez R, Gomez R, Guzman E, Insunza A, Muñoz H. et al Guía Perinatal de Chile. 1st ed.. Ministerio de Salud; 2015
• 5 Friedman D, Buyon J, Kim M, Glickstein JS. Fetal cardiac function assessed by Doppler myocardial performance index (Tei index). Ultrasound Obstet Gynecol 2003; 21 (01) 33-36
• 6 Henry A, Welsh AW. Monitoring intrahepatic cholestasis of pregnancy using the fetal myocardial performance index: a cohort study. Ultrasound Obstet Gynecol 2015; 46 (05) 571-578
• 7 Fan X, Zhou Q, Zeng S. et al. Impaired fetal myocardial deformation in intrahepatic cholestasis of pregnancy. J Ultrasound Med 2014; 33 (07) 1171-1177
• 8 Ataalla WM, Ziada DH, Gaber R, Ossman A, Bayomy S, Elemary BR. The impact of total bile acid levels on fetal cardiac function in intrahepatic cholestasis of pregnancy using fetal echocardiography: a tissue Doppler imaging study. J Matern Fetal Neonatal Med 2016; 29 (09) 1445-1450
• 9 Rodriguez M, Bombin M, Ahumada H, Bachmann M, Egaña-Ugrinovic G, Sepúlveda-Martínez A. Fetal cardiac dysfunction in pregnancies affected by intrahepatic cholestasis of pregnancy: a cohort study. J Obstet Gynaecol Res 2022; 48 (07) 1658-1667
• 10 Ovadia C, Seed PT, Sklavounos A. et al. Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses. Lancet 2019; 393 (10174): 899-909
• 11 Guerra M, Montaño I, Haye MT, Toro V, Maiz N, Fetal PR. Fetal PR interval in pregnancies with intrahepatic cholestasis of pregnancy: a case-control study. Am J Perinatol 2024; 41 (S 01): e2964-e2969